Trial Outcomes & Findings for To Access the Effects of Mucositis in Adults With Dental Implants (NCT NCT01072201)
NCT ID: NCT01072201
Last Updated: 2010-10-05
Results Overview
Percentage of Bleeding Scale: The bleeding sites are identified by either a 0 or 1. (0=no bleeding \& 1= bleeding) The number of spots between teeth that bleed are divided by number of spots between teeth that are scored.
COMPLETED
PHASE3
60 participants
6 months
2010-10-05
Participant Flow
Participant milestones
| Measure |
Total Toothpaste
Triclosan/copolymer/Fluoride
|
Ultrabrite Toothpaste
sodium fluoride control(placebo)
|
|---|---|---|
|
Overall Study
STARTED
|
30
|
30
|
|
Overall Study
COMPLETED
|
30
|
29
|
|
Overall Study
NOT COMPLETED
|
0
|
1
|
Reasons for withdrawal
| Measure |
Total Toothpaste
Triclosan/copolymer/Fluoride
|
Ultrabrite Toothpaste
sodium fluoride control(placebo)
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
0
|
1
|
Baseline Characteristics
To Access the Effects of Mucositis in Adults With Dental Implants
Baseline characteristics by cohort
| Measure |
Total Toothpaste
n=30 Participants
Triclosan/copolymer/Fluoride
|
Ultrabrite Toothpaste
n=30 Participants
sodium fluoride control (placebo)
|
Total
n=60 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
26 Participants
n=5 Participants
|
26 Participants
n=7 Participants
|
52 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
4 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
|
Age Continuous
|
57.36 years
STANDARD_DEVIATION 7.38 • n=5 Participants
|
57.83 years
STANDARD_DEVIATION 7.97 • n=7 Participants
|
57.59 years
STANDARD_DEVIATION 7.61 • n=5 Participants
|
|
Sex: Female, Male
Female
|
20 Participants
n=5 Participants
|
21 Participants
n=7 Participants
|
41 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
10 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
19 Participants
n=5 Participants
|
|
Region of Enrollment
Italy
|
30 participants
n=5 Participants
|
30 participants
n=7 Participants
|
60 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 6 monthsPercentage of Bleeding Scale: The bleeding sites are identified by either a 0 or 1. (0=no bleeding \& 1= bleeding) The number of spots between teeth that bleed are divided by number of spots between teeth that are scored.
Outcome measures
| Measure |
Total Toothpaste
n=30 Participants
Triclosan/copolymer/Fluoride
|
Ultrabrite Toothpaste
n=29 Participants
sodium fluoride control (placebo)
|
|---|---|---|
|
Bleeding on Probing
|
53.8 Percentage of bleeding sites
Standard Deviation 17.6
|
52.3 Percentage of bleeding sites
Standard Deviation 24.6
|
PRIMARY outcome
Timeframe: 6 MonthsMeasurement scale: 0 millimeter measurement= no pocket depth. 3, 4, 5, \& 6 millimeter are indications of deeper Pocket depth.
Outcome measures
| Measure |
Total Toothpaste
n=30 Participants
Triclosan/copolymer/Fluoride
|
Ultrabrite Toothpaste
n=29 Participants
sodium fluoride control (placebo)
|
|---|---|---|
|
Mean Pocket Depth
|
4.4 Millimeters
Standard Deviation 0.6
|
4.5 Millimeters
Standard Deviation 0.5
|
PRIMARY outcome
Timeframe: 6 MonthsMean Percentage (%) of dental plaque on all tooth surfaces, including implants and natural teeth. Plaque Scale is 0=no plaque and 1= dental plaque present. Percentage is derived from sum of all plaque scores divided by the number of tooth surfaces scored.
Outcome measures
| Measure |
Total Toothpaste
n=30 Participants
Triclosan/copolymer/Fluoride
|
Ultrabrite Toothpaste
n=29 Participants
sodium fluoride control (placebo)
|
|---|---|---|
|
Mean Percentage of Plaque Scores
|
13.2 percentage of dental plaque
Standard Deviation 15.6
|
16.0 percentage of dental plaque
Standard Deviation 17.8
|
Adverse Events
Total Toothpaste
Ultrabrite Toothpaste
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: GT60